Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Doxorubicin
... of 5.8% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis ... Read More
-
Radiation Therapy Equipment
... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. External Beam Radiation Therapy Equipment, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach ... Read More
-
Respiratory Inhalers
... at a CAGR of 6.0% over the analysis period 2023-2030. Manual Respiratory Inhalers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$54.4 Billion by the end ... Read More
-
Foot Care Products
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Foot Creams, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by ... Read More
-
Neuromodulation
... of 9.1% over the analysis period 2023-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... reach US$944.9 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and ... Read More
-
Contraceptives
... of 6.2% over the analysis period 2023-2030. Contraceptive Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$26.0 Billion by the end of the analysis period. ... Read More
-
Orthopedic Prosthetic Implants
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Knee Prosthesis, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$14.9 Billion by ... Read More
-
Bariatric (Obesity) Surgical Devices
... reach US$5.5 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach ... Read More
-
Anti-Infectives
... of 6.2% over the analysis period 2023-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. ... Read More
-
Cystic Fibrosis Therapeutics
... by 2030, growing at a CAGR of 15.1% over the analysis period 2023-2030. Cystic Fibrosis Medication, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$42.1 Billion ... Read More
-
Pancreatic Cancer Drugs
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Exocrine Drugs, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.2 Billion by ... Read More
-
Vertebral Compression Fracture Devices
... reach US$1.4 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Prenatal Diagnostics
... at a CAGR of 12.7% over the analysis period 2023-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$10.6 Billion by the end of ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Kidney Cancer Drugs
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.6 Billion by ... Read More
-
Cardiovascular Disease Monitoring and Diagnostic Devices
... the year 2023, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. ECG Systems, one of the segments analyzed in the report, is expected to ... Read More
-
Anticoagulants
... of 9.1% over the analysis period 2023-2030. NOACs Drug Class, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis ... Read More
-
Ovulation Test
... at a CAGR of 4.0% over the analysis period 2023-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Global Gait Analyzer Market Research Report 2024
... during the forecast period 2024-2030. In 2023 the Global Gait Analyzer production were 1,057 Units and it will be 1,908 Units in 2030, with a CAGR of 8.62% between 2024 and 2030. Europe and North ... Read More
-
Orthopedic Braces & Support, Casting and Splints
... US$6.5 Billion in the year 2023, is expected to reach US$10.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Orthopedic Braces & Supports, one of the segments analyzed in ... Read More
-
Women's Health Therapeutics
... Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Postmenopausal Osteoporosis Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$18.1 ... Read More
-
Xerostomia (Dry Mouth) Therapeutics
... reach US$1.0 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Over-the-Counter Xerostomia Drugs, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and ... Read More
-
US Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032
... reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032 US Esoteric Testing Market is valued approximately USD 6.87 Billion in 2023 and is anticipated to grow with a ... Read More
Research Assistance
